|
BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
| Catalog Number |
D139401 |
| Medical Device Problem Codes |
High Readings (2459); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Cardiac Tamponade (2226)
|
| Date of Event |
05/01/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The report indicated that during qdot micro a right ventricular outflow tract (rvot) procedure with a qdot catheter, the patient experienced pericardial effusion, and pericardial drainage was performed.Also, the impedance value increased by approximately 30o, triggering the generator's safety features and the ablation was stopped.During rvot ablation with the qdot micro catheter, the impedance value increased by approximately 30o, triggering the generator's safety features and the ablation was stopped.Immediately afterward, an echocardiogram confirmed the presence of pericardial effusion, and pericardial drainage was performed.The procedure was concluded as it was.The health problem was cardiac tamponade, and there was extended hospital stay.Contact force (cf) monitoring methods used was dashboard, vector, visitag, and coloring setting of visitag was tag index.Additional information was received which indicated that the patient¿s condition improved.The patient did not require cardiac surgery.One catheter exchange was used.Prior to noting the pericardial effusion, ablation was performed.Radiofrequency (rf) energy was used for ablation.There was no error message observed on biosense webster equipment during the procedure.The high impedance issue is not mdr reportable.
|
| |
|
Additional Manufacturer Narrative
|
|
An analysis of the product could not be performed since a physical sample was not received for evaluation.An evaluation of the manufacturing record could not be performed as the required product identification number was not provided to complete the evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was received on 08-jun-2025.It was reported that the patient fully recovered.No transseptal puncture was performed there was evidence of steam pop.Procedural activated clotting time (act) was over 300 seconds.There were no issues with flow rate change at the start of ablation.Correct catheter settings were selected on the generator.Additional filter used with the visitag was ai.The concomitant product section has been updated as the product codes for ngen generator and pump were provided.Lot number has been provided.Therefore, section d4.Lot, d4.Expiration date, and h 4.Device manufacture date have been populated.Correction to the initial report: full udi has been populated to field d4.Primary udi number.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
A manufacturing record evaluation was performed for the finished device lot number 31409925l and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|